Federal contractor profile
ABVIRO LLC
UEI K3L6KXJ9B6M7CAGE 75YF3
Overview
- Legal name
- ABVIRO LLC
- Registered location
- BETHESDA, MD, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Mar 24, 2026
Read company summary
ABVIRO LLC is associated with UEI K3L6KXJ9B6M7 and CAGE 75YF3 in public federal records. AcornBids currently links 2 prime awards totaling $40.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists BETHESDA, MD, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- ABVIRO LLC
- UEI
- K3L6KXJ9B6M7
- CAGE
- 75YF3
- Registered address
- 4800 HAMPDEN LN STE 200, BETHESDA, MD, 20814, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Aug 14, 2025
- Initial registration
- Jul 3, 2014
- Entity start
- May 8, 2014
- SAM updated
- Aug 14, 2025
- Registration expires
- Aug 14, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- MD, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93023C00055TO CONDUCT A PHASE 2 DENGUE HUMAN CHALLENGE CLINICAL TRIAL OF ABVIRO ANTI-DENGUE MONOCLONAL ANTIBODY (MAB) AV-1. | Department of Health and Human Services | $11.3M | Sep 25, 2023 | Dec 31, 2026 |
| HHSN272201600028CIGF::OT::IGF - A BROAD-SPECTRUM ANTIBODY THERAPEUTIC AGAINST FLAVIVIRUS INFECTIONS. | Department of Health and Human Services | $29.2M | Sep 19, 2016 | Sep 30, 2022 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Aug 14, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jul 3, 2014 |
| Entity start | May 8, 2014 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BRENNAN KLOSE | Government business | Contact method not published | SAM registration | Not available |
| MICHAEL KERR | Alternate government business | Contact method not published | SAM registration | Not available |
| BRENNAN KLOSE | Electronic business | Contact method not published | SAM registration | Not available |
| MICHAEL KERR | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit